Table 3 Clinical characteristics of patients using chronic postoperative opioids
Clinical Characteristic | 3 m + Chronic Postoperative Opioid Use (N = 136) | 12 m + Chronic Postoperative Opioid Use (N = 116) | ||||
|---|---|---|---|---|---|---|
Naïve N = 66 (%) | Non-Naïve N = 70 (%) | p value | Naïve N = 53 (%) | Non-Naïve N = 63 (%) | p value | |
Gender | 0.3 | 0.7 | ||||
Male | 44 (63%) | 47 (71%) | 38 (72%) | 42 (67%) | ||
Female | 26 (37%) | 19 (29%) | 15 (28%) | 21 (33%) | ||
Age (years) | 0.7 | 0.6 | ||||
Mean [SD] | 62.3 [12.34] | 61.6 [10.79] | 62.7 [12.23] | 61.6 [10.93] | ||
Range | 31.4–88.2 | 23.4–82.0 | 31.8–88.2 | 23.4–82.0 | ||
Social Habits | ||||||
Prior Tobacco | 53 (80%) | 53 (76%) | 0.6 | 43 (81%) | 46 (73%) | 0.4 |
Prior Alcohol | 49 (74%) | 49 (70%) | 0.3 | 39 (74%) | 43 (68%) | 0.5 |
Clinical Stage | 0.08 | 0.2 | ||||
In Situ (Stage 0) | 0 (0%) | 1 (1%) | 0 (0%) | 1 (2%) | ||
I | 7 (11%) | 13 (19%) | 6 (11%) | 13 (21%) | ||
II | 14 (21%) | 8 (11%) | 12 (25%) | 8 (13%) | ||
III | 4 (6%) | 11 (16%) | 3 (6%) | 7 (11%) | ||
IV | 41 (62%) | 37 (53%) | 31 (59%) | 34 (54%) | ||
Primary Tumour Location | 0.03 | 0.06 | ||||
Oral Cavity | 59 (89%) | 48 (69%) | 47 (89%) | 43 (68%) | ||
Salivary Gland | 2 (3%) | 7 (10%) | 1 (2%) | 7 (11%) | ||
Paranasal Sinus | 2 (3%) | 8 (11%) | 2 (4%) | 7 (11%) | ||
Other | 3 (5%) | 7 (10%) | 3 (6%) | 6 (10%) | ||
Free Flap | 1 | 0.9 | ||||
Soft Tissue | 49 (74%) | 52 (74%) | 41 (77%) | 47 (75%) | ||
Bone | 13 (20%) | 14 (20%) | 10 (19%) | 13 (21%) | ||
Soft Tissue + bone | 4 (6%) | 4 (6%) | 2 (4%) | 3 (5%) | ||
Treatment | 0.2 | 0.4 | ||||
Surgery Alone | 19 (29%) | 29 (41%) | 19 (36%) | 28 (44%) | ||
Surgery + Adjuvant | 47 (71%) | 41 (59%) | 34 (64%) | 35 (56%) | ||